Insider Transactions in Q1 2025 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2025
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
123
-0.08%
|
$246
$2.26 P/Share
|
|
Jan 17
2025
|
Benjamin Halladay Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9
-0.0%
|
$18
$2.27 P/Share
|